Dominant antigenic peptides located at the heavy chain terminal of botulinum neurotoxin B contain receptor-binding sites for synaptotagmin II

Biochemical and Biophysical Research Communications

Volumn 374, Issue 2, 2008, Pages 331-335

  Shi, Jing ^a   Bao, Shizhong ^a   Yin, Jun ^a   Cai, Kun ^a   Hou, Xiaojun ^a   Xiao, Le ^a   Tu, Wei ^a   Wang, Qin ^a   Wang, Hui ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Botulinum neurotoxin; Dominant antigenic epitopes; Receptor binding sites

Indexed keywords

AMINO ACID; BOTULINUM TOXIN B; EPITOPE; PEPTIDE; PEPTIDE P1; PEPTIDE P2; PEPTIDE P3; PEPTIDE P4; PEPTIDE P5; PEPTIDE P6; PEPTIDE P7; PEPTIDE P8; PEPTIDE VACCINE; POLYCLONAL ANTIBODY; SYNAPTOTAGMIN II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BINDING AFFINITY; BINDING SITE; BOTULISM; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; HEAVY CHAIN; IMMUNITY; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; INTOXICATION; LETHALITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL VACCINES; BINDING SITES; BOTULINUM TOXINS; BOTULISM; FEMALE; HUMANS; IMMUNIZATION; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; RECOMBINANT PROTEINS; SYNAPTOTAGMIN II;

MUS;

EID: 48549102893     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.048     Document Type: Article

References (20)

1. Atassi M.Z., and Oshima M. Structure, activity and immune recognition of botulinum neurotoxins. Crit. Rev. Immunol. 19 3 (1999) 219-260
2. Hathaway C.L. Toxigenic clostridia. Clin. Microbiol. 3 (1999) 66-98
3. Oguma K., Fujinaga Y., and Inoue K. Structure and function of Clostridium botulinum toxins. Microb. Immunol. 39 (1995) 161-168
4. Lacy D.B., and Stevens C.R. Sequence Homology and Structural Analysis of the Clostridial Neurotoxins. J. Mol. Biol. 291 (1999) 1091-1104
5. Schiavo G., Matteoli M., and Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80 2 (2000) 717
6. Simpson L.L. Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 167-193
7. Montecucco C., and Schiavo G. Mechanism of action of tetanus and botulinum neurotoxins. Mol. Microbiol. 13 (1994) 1-9
8. Montecucco C., Papini E., and Schiavo G. Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett. 346 1 (1994) 92-98
9. Swaminathan S., Eswaramoorthy S., and Kumaran D. Structure and enzymatic activity of botulinum neurotoxins. Movement 19 8 (2004) S17-S22
10. Turton K., Chaddock J.A., and Acharya K.R. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem. Sci. 27 (2002) 552-558
11. Kathryn T., Chaddock John A., and Ravi Acharya K. Botulinum and tetanus neurotoxins:structure, function and therapeutic utility. Trends Biochem. Sci. 27 11 (2002) 552-558
12. Dertzbaugh M.T., and West M.W. Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum. Vaccine 14 16 (1996) 1538-1544
13. Cenci Di Bello I., Poulain B., Shone C.C., and Tauc L. Antagonism of the intracellular action of botulinum neurotoxin type A with monoclonal antibodies that map to light-chain epitopes. Eur. J. Biochem. 219 (1994) 161-169
14. Dong M., et al. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 162 (2003) 1293-1303
15. Halpern J.L., and Neale E.A. Neurospecific binding, internalization, and retrograde axonal transport. Curr. Top. Microbiol. Immunol. 195 (1995) 221-241
16. Rummel A., et al. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 279 (2004) 30865-30870
17. Nishiki T., Tokuyama Y., Kamata Y., et al. Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA. Neurosci. Lett. 208 2 (1996) 105-108
18. Li L., and Singh B.R. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay. J. Nat. Toxins 7 3 (1998) 215-226
19. Yowler B.C., Kensinger R.D., and Schengrund C.L. Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I. J. Biol. Chem. 277 36 (2002) 32815-32819
20. Claudia V., Ornella R., Carlotta G., et al. Entering neurons: botulinum toxins and synaptic vesicle recycling. EMBO Rep. 7 10 (2006) 995-999